October 5, 2014 | According to a “Globes” report, Israeli companies have raised $3.5 billion on the US capital market in 2014 through a number of public offerings on the countries largest stock exchanges. High-tech companies like CyberArk, which recently raised $85.8 million in its NASDAQ IPO, Varonis Systems, Mobileye, Borderfree, and biotech companies BioBlast Pharma and MacroCure all listed IPOs in 2014. The companies sought to raise extra funds through IPOs for the continued development of their product or service and to overcome dry periods. In addition, high-tech companies’ private placement front from funds, investment companies and angel investors also spiked in comparison to records from previous years.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments